diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2014396-106diaendo-6646Research ArticleКардиологияCardiologyЭластические свойства сосудов, показатели функционального состояния почек и почечного кровотока у больных с ишемической болезнью сердца, гипертонической болезнью и сопутствующим сахарным диабетом 2 типаArterial stiffness, renal function and renal blood flow in patients with coronary artery disease, arterial hypertension and type 2 diabetes mellitusОсколаЕлена ВасильевнаOskolaElena Vasilievna

MD, Research Fellow, Department of Angiology, Myasnikov Clinical Cardiology Institute

oelen2010@yandex.ruШубинаАнна ТимофеевнаShubinaAnna Timofeevna

MD, PhD, Research Associate, Department of Angiology, Myasnikov Clinical Cardiology Institute

s_anna@list.ruЗаироваАлсу РафхатовнаZairovaAlsu Rafhatovna

кандидат медицинских наук, научный сотрудник отдела  новых методов диагностики Института клинической кардиологии им. А.Л.Мясникова

MD, PhD, Research Associate, Office of innovative diagnostics, Myasnikov Clinical Cardiology Institute

alsu-zar@rambler.ruАндреевскаяМарина ВладимировнаAndreevskayaMarina Vladimirovna

младший научный сотрудник лаборатории ультразвуковых методов исследования  отдела новых методов диагностики Института клинической кардиологии им. А.Л.Мясникова

MD, Junior Research Associate, Laboratory of ultrasonography, Office of innovative diagnostics, Myasnikov Clinical Cardiology Institute

marineracrim@mail.ruБогиеваРоксана МирабовнаBogievaRoksana Mirabovna

кандидат медицинских наук, младший научный сотрудник  лаборатории ультразвуковых методов исследования  отдела  новых методов диагностики Института клинической кардиологии им. А.Л.Мясникова.

MD, PhD, Junior Research Associate, Laboratory of ultrasonography, Office of innovative diagnostics, Myasnikov Clinical Cardiology Institute

roksuta76@gmail.comПогореловаОльга АлександровнаPogorelovaOlga Alexandrovna

кандидат медицинских наук, старший научный сотрудник  отдела новых методов диагностики Института клинической кардиологии им. А.Л.Мясникова

MD, PhD, Senior Research Associate, Office of innovative diagnostics, Myasnikov Clinical Cardiology Institute

pogorelova.olya@gmail.comБолотинаМарина ГригорьевнаBolotinaMarina Grigorievna

врач-эндокринолог Института клинической кардиологии им. А.Л.Мясникова.

MD, endocrinologist, Myasnikov Clinical Cardiology Institute

manya8888@rambler.ruБалахоноваТатьяна ВалентиновнаBalahonovaTatiana Valentinovna

MD, PhD, Professor, Office of innovative diagnostics, Myasnikov Clinical Cardiology Institute

tvbdoc@gmail.comРогозаАнатолий НиколаевичRogozaAnatoliy Nikolaevich

Doctor of biological sciences, Professor, Head of Office of Innovative Diagnostics, Myasnikov Clinical Cardiology Institute

anrogoza@gmail.comКарповЮрий АлександровичKarpovYury Alexandrovich

доктор медицинских наук, профессор, руководитель отдела ангиологии Института клинической кардиологии им. А.Л.Мясникова, заместитель генерального директора Российского кардиологического научно-производственного комплекса

MD, PhD, Professor, Head of Department of Angiology, Myasnikov Clinical Cardiology Institute, associate Director of Cardiology Research Complex

yuri_karpov@inbox.ruФГБУ «Российский кардиологический научно-производственный комплекс», МоскваРоссияCardiology Research Complex, MoscowRussian Federation20140107201417396106Copyright © Оскола Е.В., Шубина А.Т., Заирова А.Р., Андреевская М.В., Богиева Р.М., Погорелова О.А., Болотина М.Г., Балахонова Т.В., Рогоза А.Н., Карпов Ю.А., 20142014Оскола Е.В., Шубина А.Т., Заирова А.Р., Андреевская М.В., Богиева Р.М., Погорелова О.А., Болотина М.Г., Балахонова Т.В., Рогоза А.Н., Карпов Ю.А.Oskola E.V., Shubina A.T., Zairova A.R., Andreevskaya M.V., Bogieva R.M., Pogorelova O.A., Bolotina M.G., Balahonova T.V., Rogoza A.N., Karpov Y.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6646сахарный диабет 2 типажесткость сосудовпочечный кровотокдисфункция почекtype 2 diabetes mellitusvascular stiffnessrenal blood flowrenal dysfunctionCardiology Research Complex, MoscowReferencesVlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318-1327. doi: 10.1016/j.jacc.2009.10.061Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318-1327. doi: 10.1016/j.jacc.2009.10.061Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085-2090. doi: 10.1161/01.CIR.0000033824.02722.F7Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085-2090. doi: 10.1161/01.CIR.0000033824.02722.F7Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588-2605. doi: 10.1093/eurheartj/ehl254Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588-2605. doi: 10.1093/eurheartj/ehl254Della-Morte D, Ricordi C, Guadagni F, Rundek T. Measurement of subclinical carotid atherosclerosis may help in predicting risk for stroke in patients with diabetes. Metab Brain Dis. 2013;28(3):337-339. doi: 10.1007/s11011-013-9385-3Della-Morte D, Ricordi C, Guadagni F, Rundek T. Measurement of subclinical carotid atherosclerosis may help in predicting risk for stroke in patients with diabetes. Metab Brain Dis. 2013;28(3):337-339. doi: 10.1007/s11011-013-9385-3Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998;32(3):570-574. doi: 10.1161/01.HYP.32.3.570Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998;32(3):570-574. doi: 10.1161/01.HYP.32.3.570Simons PC, Algra A, Bots ML, Grobbee DE, van der Graaf Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation. 1999;100(9):951-957. doi: 10.1161/01.CIR.100.9.951Simons PC, Algra A, Bots ML, Grobbee DE, van der Graaf Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation. 1999;100(9):951-957. doi: 10.1161/01.CIR.100.9.951Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis. 2009;205(2):472-476. doi: 10.1016/j.atherosclerosis.2008.12.027Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis. 2009;205(2):472-476. doi: 10.1016/j.atherosclerosis.2008.12.027Трунина ЕН, Петунина НА, Чорбинская СА. Ингибиторы дипептидилпептидазы-4 в лечении сахарного диабета 2 типа. Возможности кардиопотекции. Сахарный диабет. 2011;(2):59-64. [Trunina EN, Petunina NA, Chorbinskaya SA. Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection. Diabetes mellitus. 2011;(2):59-64.] doi: 10.14341/2072-0351-5636Трунина ЕН, Петунина НА, Чорбинская СА. Ингибиторы дипептидилпептидазы-4 в лечении сахарного диабета 2 типа. Возможности кардиопотекции. Сахарный диабет. 2011;(2):59-64. [Trunina EN, Petunina NA, Chorbinskaya SA. Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection. Diabetes mellitus. 2011;(2):59-64.] doi: 10.14341/2072-0351-5636Шестакова МВ, Чугунова ЛА, Шамхалова МШ, Дедов И.И.. Диабетическая нефропатия: достижения в диагностике, профилактике и лечении. Сахарный диабет. 2005; (3):22-25. [Shestakova MV, Chugunova LA, Shamkhalova MS, Dedov II. Diabeticheskaya nefropatiya: dostizheniya v diagnostike,profilaktike i lechenii. Diabetes mellitus. 2005;(3):22-25.] doi: 10.14341/2072-0351-5574Шестакова МВ, Чугунова ЛА, Шамхалова МШ, Дедов И.И.. Диабетическая нефропатия: достижения в диагностике, профилактике и лечении. Сахарный диабет. 2005; (3):22-25. [Shestakova MV, Chugunova LA, Shamkhalova MS, Dedov II. Diabeticheskaya nefropatiya: dostizheniya v diagnostike,profilaktike i lechenii. Diabetes mellitus. 2005;(3):22-25.] doi: 10.14341/2072-0351-5574Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62(4):1402-1407. doi:10.1111/j.1523-1755.2002.kid571.xHenry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62(4):1402-1407. doi:10.1111/j.1523-1755.2002.kid571.xHermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CD. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol. 2007;18(6):1942-1952. doi: 10.1681/ASN.2006111217Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CD. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol. 2007;18(6):1942-1952. doi: 10.1681/ASN.2006111217Taniwaki H, Nishizawa Y, Kawagishi T, Ishimura E, Emoto M, Okamura T, et al. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care. 1998;21(11):1848-1855. doi: 10.2337/diacare.21.11.1848Taniwaki H, Nishizawa Y, Kawagishi T, Ishimura E, Emoto M, Okamura T, et al. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care. 1998;21(11):1848-1855. doi: 10.2337/diacare.21.11.1848Takegoshi T, Hirai J, Shimada T, Saga T, Kitoh C. The correlation between pulse wave velocity and diabetic angiopathy. Nihon Ronen Igakkai Zasshi. 1991;28(5):664-667. doi: 10.3143/geriatrics.28.664Takegoshi T, Hirai J, Shimada T, Saga T, Kitoh C. The correlation between pulse wave velocity and diabetic angiopathy. Nihon Ronen Igakkai Zasshi. 1991;28(5):664-667. doi: 10.3143/geriatrics.28.664Schiffrin EL, Lipman ML, Mann JF.Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85-97. doi: 10.1161/CIRCULATIONAHA.106.678342Schiffrin EL, Lipman ML, Mann JF.Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85-97. doi: 10.1161/CIRCULATIONAHA.106.678342Ahmed N, Thornalley PJ. Роль конечных продуктов гликирования в патогенезе осложнений сахарного диабета. Русский медицинский журнал. 2009;17(9): 642- 650.[ Ahmed N, Thornalley PJ. Rol' konechnykh produktov glikirovaniya v patogeneze oslozhneniy sakharnogo diabeta. Russkiy meditsinskiy zhurnal. 2009;17(9): 642- 650.]Ahmed N, Thornalley PJ. Роль конечных продуктов гликирования в патогенезе осложнений сахарного диабета. Русский медицинский журнал. 2009;17(9): 642- 650.[ Ahmed N, Thornalley PJ. Rol' konechnykh produktov glikirovaniya v patogeneze oslozhneniy sakharnogo diabeta. Russkiy meditsinskiy zhurnal. 2009;17(9): 642- 650.]Huang K, Huang J, Xie X, Wang S, Chen C, Shen X, et al. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Free Radic Biol Med. 2013;65:528-540. doi: 10.1016/j.freeradbiomed.2013.07.029Huang K, Huang J, Xie X, Wang S, Chen C, Shen X, et al. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Free Radic Biol Med. 2013;65:528-540. doi: 10.1016/j.freeradbiomed.2013.07.029Raj DS, Choudhury D, Welbourne TC, Levi M. Advanced glycation end products: a Nephrologist's perspective. Am J Kidney Dis. 2000;35(3):365-380. doi: 10.1016/S0272-6386(00)70189-2Raj DS, Choudhury D, Welbourne TC, Levi M. Advanced glycation end products: a Nephrologist's perspective. Am J Kidney Dis. 2000;35(3):365-380. doi: 10.1016/S0272-6386(00)70189-2International Diabetes Federation. Chapter 14: Kidney damage. Global Guideline for Type 2 Diabetes. Clinical Guidelines Task Force. 2005; 54-58. Available from: http://www.idf.org/webdata/docs/GGT2D%2014%20Kidney%20damade.pdfInternational Diabetes Federation. Chapter 14: Kidney damage. Global Guideline for Type 2 Diabetes. Clinical Guidelines Task Force. 2005; 54-58. Available from: http://www.idf.org/webdata/docs/GGT2D%2014%20Kidney%20damade.pdfАндреевская МВ, Чихладзе НМ, Саидова МА. Возможности ультразвуковых методов оценки ригидности аорты и ее значимость при патологии сердца и сосудов. Ультразвуковая и функциональная диагностика. 2009;(2):91-97. [Andreevskaya MV, Chikhladze NM, Saidova MA. Aortic Stiffness Ultrasound Assessment in Cardiovascular Pathology. Ulʹtrazvukovai︠a︡ i funkt︠s︡ionalʹnai︠a︡ diagnostika. 2009;(2):91-97.]Андреевская МВ, Чихладзе НМ, Саидова МА. Возможности ультразвуковых методов оценки ригидности аорты и ее значимость при патологии сердца и сосудов. Ультразвуковая и функциональная диагностика. 2009;(2):91-97. [Andreevskaya MV, Chikhladze NM, Saidova MA. Aortic Stiffness Ultrasound Assessment in Cardiovascular Pathology. Ulʹtrazvukovai︠a︡ i funkt︠s︡ionalʹnai︠a︡ diagnostika. 2009;(2):91-97.]Рогоза АН, Балахонова ТВ, Чихладзе НМ, и др. Современные методы оценки состояния сосудов у больных артериальной гипертонией. Москва: Атмосфера; 2008.[Rogoza AN, Balakhonova TV, Chikhladze NM, i dr. Sovremennye metody otsenki sostoyaniya sosudov u bol'nykh arterial'noy gipertoniey. Moskva: Atmosfera;2008.]Рогоза АН, Балахонова ТВ, Чихладзе НМ, и др. Современные методы оценки состояния сосудов у больных артериальной гипертонией. Москва: Атмосфера; 2008.[Rogoza AN, Balakhonova TV, Chikhladze NM, i dr. Sovremennye metody otsenki sostoyaniya sosudov u bol'nykh arterial'noy gipertoniey. Moskva: Atmosfera;2008.]Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101-107. doi: 10.5551/jat.13.101Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101-107. doi: 10.5551/jat.13.101Laurent S, Caviezel B, Beck L, Girerd X, Billaud E, Boutouyrie P, et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension. 1994;23(6 Pt 2):878-883. doi: 10.1161/01.HYP.23.6.878Laurent S, Caviezel B, Beck L, Girerd X, Billaud E, Boutouyrie P, et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension. 1994;23(6 Pt 2):878-883. doi: 10.1161/01.HYP.23.6.878Puttermans T, Nemery C. Diabetes: the use of color Doppler Sonography for the assessment to vascular complications. Eur J Ultrasound. 1998;7(1):15-22. doi: 10.1016/S0929-8266(98)00008-1Puttermans T, Nemery C. Diabetes: the use of color Doppler Sonography for the assessment to vascular complications. Eur J Ultrasound. 1998;7(1):15-22. doi: 10.1016/S0929-8266(98)00008-1Cameron JD1, Bulpitt CJ, Pinto ES, Rajkumar C. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care. 2003;26(7):2133-2138. doi: 10.2337/diacare.26.7.2133Cameron JD1, Bulpitt CJ, Pinto ES, Rajkumar C. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care. 2003;26(7):2133-2138. doi: 10.2337/diacare.26.7.2133Chen Y, Huang Y, Li X, Xu M, Bi Y, Zhang Y, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine. 2009;36(2):262-267. doi: 10.1007/s12020-009-9221-zChen Y, Huang Y, Li X, Xu M, Bi Y, Zhang Y, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine. 2009;36(2):262-267. doi: 10.1007/s12020-009-9221-zCameron JD, Cruickshank JK. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol. 2007;34(7):677-682. doi: 10.1111/j.1440-1681.2007.04659.xCameron JD, Cruickshank JK. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol. 2007;34(7):677-682. doi: 10.1111/j.1440-1681.2007.04659.xAuthors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-3087. doi: 10.1093/eurheartj/eht108Authors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-3087. doi: 10.1093/eurheartj/eht108Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004;25(21):1880-1890. doi: 10.1016/j.ehj.2004.07.027Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004;25(21):1880-1890. doi: 10.1016/j.ehj.2004.07.027Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107(22):2864-2869. doi: 10.1161/01.CIR.0000069826.36125.B4Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107(22):2864-2869. doi: 10.1161/01.CIR.0000069826.36125.B4Chirinos JA, Segers P, Gillebert TC, De Buyzere ML, Van Daele CM, Khan ZA, et al. Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study. Diabetes Care. 2013;36(8):2359-2365. doi: 10.2337/dc12-1463Chirinos JA, Segers P, Gillebert TC, De Buyzere ML, Van Daele CM, Khan ZA, et al. Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study. Diabetes Care. 2013;36(8):2359-2365. doi: 10.2337/dc12-1463Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58(5):839-846. doi: 10.1161/HYPERTENSIONAHA.111.177469Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58(5):839-846. doi: 10.1161/HYPERTENSIONAHA.111.177469Bruno RM, Daghini E, Landini L, Versari D, Salvati A, Santini E, et al. Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes. Diabetologia. 2011;54(9):2430-2439. doi: 10.1007/s00125-011-2148-yBruno RM, Daghini E, Landini L, Versari D, Salvati A, Santini E, et al. Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes. Diabetologia. 2011;54(9):2430-2439. doi: 10.1007/s00125-011-2148-yOhta Y, Fujii K, Arima H, Matsumura K, Tsuchihashi T, Tokumoto M, et al. Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens. 2005;23(10):1905-1911. doi: 10.1097/01.hjh.0000181323.44162.01Ohta Y, Fujii K, Arima H, Matsumura K, Tsuchihashi T, Tokumoto M, et al. Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens. 2005;23(10):1905-1911. doi: 10.1097/01.hjh.0000181323.44162.01Bouchi R, Babazono T, Mugishima M, Yoshida N, Nyumura I, Toya K, et al. Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care. 2011;34(12):2570-2575. doi: 10.2337/dc11-1020Bouchi R, Babazono T, Mugishima M, Yoshida N, Nyumura I, Toya K, et al. Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care. 2011;34(12):2570-2575. doi: 10.2337/dc11-1020Hamano K, Nitta A, Ohtake T, Kobayashi S. Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients. Diabetes Care. 2008;31(9):1853-1857. doi: 10.2337/dc08-0168Hamano K, Nitta A, Ohtake T, Kobayashi S. Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients. Diabetes Care. 2008;31(9):1853-1857. doi: 10.2337/dc08-0168Munakata M, Miura Y, Yoshinaga K; J-TOPP study group. Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: the J-TOPP study. J Hypertens. 2009;27(7):1466-1471. doi: 10.1097/HJH.0b013e32832b4740Munakata M, Miura Y, Yoshinaga K; J-TOPP study group. Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: the J-TOPP study. J Hypertens. 2009;27(7):1466-1471. doi: 10.1097/HJH.0b013e32832b4740Taniwaki H, Nishizawa Y, Kawagishi T, Ishimura E, Emoto M, Okamura T, et al. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care. 1998;21(11):1848-1855. doi: 10.2337/diacare.21.11.1848Taniwaki H, Nishizawa Y, Kawagishi T, Ishimura E, Emoto M, Okamura T, et al. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care. 1998;21(11):1848-1855. doi: 10.2337/diacare.21.11.1848Zhan WW, Chen YH, Zhang YF, Zhu Y, Lin YY, Ren XP,et al. Carotid stiffness and microalbuminuria in patients with type 2 diabetes. Endocrine. 2009;35(3):409-413. doi: 10.1007/s12020-009-9172-4Zhan WW, Chen YH, Zhang YF, Zhu Y, Lin YY, Ren XP,et al. Carotid stiffness and microalbuminuria in patients with type 2 diabetes. Endocrine. 2009;35(3):409-413. doi: 10.1007/s12020-009-9172-4

The authors declare that there are no conflicts of interest present.